
Results
16
Financially healthy companies listed on Asian stock exchanges with an impressive track record.
16 companies
Laurus Labs
Market Cap: ₹1.0t
Manufactures and sells medicines and active pharmaceutical ingredients (APIs) in India and internationally.
LAURUSLABS
₹1,850.00
7D
0.8%
1Y
114.3%
Biocytogen Pharmaceuticals (Beijing)
Market Cap: HK$61.5b
A biotechnology company, engages in the research and development of novel antibody-based drugs and pre-clinical research services in the People’s Republic of China, the United States, and internationally.
2315
HK$67.10
7D
19.6%
1Y
171.0%
Anthem Biosciences
Market Cap: ₹502.2b
Operates as a contract research, development, and manufacturing organization in India, rest of Asia, North America, Europe, and internationally.
ANTHEM
₹878.40
7D
6.4%
1Y
16.4%
Emcure Pharmaceuticals
Market Cap: ₹378.9b
Emcure Pharmaceuticals Limited provide quality and affordable healthcare solutions worldwide.
EMCURE
₹2,009.60
7D
2.6%
1Y
38.2%
Sai Life Sciences
Market Cap: ₹306.4b
Operates as a contract research, development, and manufacturing organization (CRDMO) in India and internationally.
SAILIFE
₹1,463.60
7D
5.0%
1Y
62.1%
Neuland Laboratories
Market Cap: ₹294.5b
Engages in the manufacture and sale of active pharmaceutical ingredients (APIs) in India, Europe, the United States, and internationally.
524558
₹22,505.60
7D
12.7%
1Y
72.9%
Rubicon Research
Market Cap: ₹274.0b
Operates as a specialty pharmaceutical company in India, the United States, and internationally.
RUBICON
₹1,653.60
7D
5.0%
1Y
n/a
Acutaas Chemicals
Market Cap: ₹265.8b
Engages in the research and development, manufacture, and sale of pharmaceutical intermediates in India and internationally.
ACUTAAS
₹3,153.40
7D
-3.9%
1Y
139.5%
Aether Industries
Market Cap: ₹216.9b
Produces and sells advanced intermediates and specialty chemicals in India and internationally.
AETHER
₹1,612.70
7D
1.5%
1Y
114.5%
Granules India
Market Cap: ₹213.2b
Manufactures and sells active pharmaceutical ingredients (APIs), pharmaceutical formulation intermediates (PFIs), finished dosages (FDs), and peptides CDMO in India and internationally.
532482
₹865.10
7D
2.5%
1Y
87.9%
Jinyu Bio-technology
Market Cap: CN¥15.0b
Engages in the research and development, production, and sale of veterinary biological products in China and internationally.
600201
CN¥13.75
7D
4.2%
1Y
59.3%
Inner Mongolia Furui Medical Science
Market Cap: CN¥11.8b
Inner Mongolia Furui Medical Science Co., Ltd.
300049
CN¥44.52
7D
-4.6%
1Y
-8.8%
Shilpa Medicare
Market Cap: ₹160.2b
Manufactures and sells active pharmaceutical ingredients (APIs), finished dosage formulations, biosimilars, and contract development and manufacturing organisation in India, the United States, Europe, and internationally.
530549
₹804.35
7D
11.5%
1Y
77.4%
Viyash Scientific
Market Cap: ₹114.1b
Operates as a veterinary pharmaceutical Company in India, the United States, Spain, and internationally.
512529
₹262.95
7D
-3.9%
1Y
53.2%
Strides Pharma Science
Market Cap: ₹92.4b
A pharmaceutical company, engages in the development, manufacturing, and marketing of pharmaceutical products in North America, Australia, Africa, Europe, India, the rest of Asia, and internationally.
STAR
₹993.80
7D
2.4%
1Y
14.6%
Sakar Healthcare
Market Cap: ₹21.2b
Research, develops, manufactures, and sells pharmaceutical products in India.
SAKAR
₹935.80
7D
5.1%
1Y
185.4%